(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 6.62% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 10.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.21%.
Lantheus Holdings's revenue in 2026 is $1,556,313,000.On average, 15 Wall Street analysts forecast LNTH's revenue for 2026 to be $98,169,642,976, with the lowest LNTH revenue forecast at $91,185,499,493, and the highest LNTH revenue forecast at $108,482,677,278. On average, 14 Wall Street analysts forecast LNTH's revenue for 2027 to be $109,461,762,813, with the lowest LNTH revenue forecast at $100,584,720,629, and the highest LNTH revenue forecast at $127,346,391,919.
In 2028, LNTH is forecast to generate $123,756,411,624 in revenue, with the lowest revenue forecast at $108,743,766,754 and the highest revenue forecast at $144,708,842,073.